La proteína recombinante 1-desoxi-D-xilulosa 5-fosfato reductoisomerasa apicoplastídica de Plasmodium falciparum y su interacción con aptámeros

S Manresa Guille - 2020 - dspace.uvic.cat
La especie humana se ve gravemente afectada por la enfermedad de la malaria, que es
una infección parasitaria causada por cinco especies distintas de Plasmodium, de las …

Enzymes of Isoprenoid Biosynthesis and Control of Malarial Parasite Plasmodium falciparum

MO Alkurbi, S Alghamdi, A Aslam, Q Aalm - Drug Targets for Plasmodium …, 2024 - Springer
There is high importance for the control of parasite Plasmodium falciparum which is
responsible for causing malaria. Following the classical mevalonate pathway, the metabolite …

The druggable antimalarial target PfDXR: overproduction strategies and kinetic characterization

JL Goble, H Johnson, J De Ridder… - Protein and Peptide …, 2013 - ingentaconnect.com
Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR) is a
key enzyme in the synthesis of isoprenoids in the malaria parasite, using a pathway that is …

[HTML][HTML] Selection of an Aptamer against the Enzyme 1-deoxy-D-xylulose-5-phosphate Reductoisomerase from Plasmodium falciparum

C Roca, Y Avalos-Padilla, B Prieto-Simón, V Iglesias… - Pharmaceutics, 2022 - mdpi.com
The methyl erythritol phosphate (MEP) pathway of isoprenoid biosynthesis is essential for
malaria parasites and also for several human pathogenic bacteria, thus representing an …

Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene

AR Odom, WC Van Voorhis - Molecular and biochemical parasitology, 2010 - Elsevier
Novel antimalarial drugs are urgently needed to treat severe malaria caused by Plasmodium
falciparum. Isoprenoid biosynthesis is a promising target pathway, since the biosynthetic …

[HTML][HTML] New insight into isoprenoids biosynthesis process and future prospects for drug designing in Plasmodium

GS Saggu, ZR Pala, S Garg, V Saxena - Frontiers in Microbiology, 2016 - frontiersin.org
The MEP (Methyl Erythritol Phosphate) isoprenoids biosynthesis pathway is an attractive
drug target to combat malaria, due to its uniqueness and indispensability for the parasite. It …

A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis

W Wu, Z Herrera, D Ebert, K Baska… - Antimicrobial agents …, 2015 - Am Soc Microbiol
The apicoplast is an essential plastid organelle found in Plasmodium parasites which
contains several clinically validated antimalarial-drug targets. A chemical rescue screen …

Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC

S Konzuch, T Umeda, J Held, S Hähn… - Journal of medicinal …, 2014 - ACS Publications
1-Deoxy-d-xylulose 5-phosphate reductoisomerase of Plasmodium falciparum (Pf IspC, Pf
Dxr), believed to be the rate-limiting enzyme of the nonmevalonate pathway of isoprenoid …

Inhibition of the non-Mevalonate Isoprenoid pathway by reverse Hydroxamate analogues of Fosmidomycin

C Lienau, S Konzuch, T Gräwert, B Illarionov… - Procedia …, 2015 - Elsevier
The non-mevalonate (methylerythritol phosphate, MEP) pathway for isoprenoid biosynthesis
is essential in Plasmodium spp.., but is absent in the human host. The pathway is a clinically …

[HTML][HTML] Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum

MB Cassera, EF Merino, VJ Peres… - Memórias do Instituto …, 2007 - SciELO Brasil
In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl
diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the …